// App-Quantinova.ai

6703 : A fully synthetic EphA2/4-1BB tumor-targeted immune cell agonist (TICATM) induces tumor localized 4-1BB agonism

Researchers

Presenter

  • Sailaja Battula

Principal Investigators

  • Gemma Mudd

  • Punit Upadhyaya

  • Julia Kristensson

  • Marianna Kleyman

  • Elizabeth Repash

  • Jessica Kublin

  • Jun Ma

  • Eric Haines

  • Kristen Hurov

  • Liuhong Chen

  • Johanna Lahdenranta

  • Paul Beswick

  • Kevin McDonnell

  • Nicholas Keen

Medical Centers

  • Quiet Therapeutics, Lexington, MA.

  • Bicycle Therapeutics, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Natural Killer cells

  • Cluster of differentiation 8A

  • Interferon-gamma

Drug/Treatment

  • Erythropoietin

  • Interferon Gamma

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved